Logo image of FLD

FOLD HOLDINGS INC (FLD) Stock Fundamental Analysis

NASDAQ:FLD - Nasdaq - US29103K1007 - Common Stock - Currency: USD

4.01  -0.01 (-0.25%)

After market: 4.15 +0.14 (+3.49%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to FLD. FLD was compared to 237 industry peers in the Capital Markets industry. FLD has a bad profitability rating. Also its financial health evaluation is rather negative. FLD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FLD had negative earnings in the past year.
FLD had a negative operating cash flow in the past year.
In multiple years FLD reported negative net income over the last 5 years.
FLD had a negative operating cash flow in each of the past 5 years.
FLD Yearly Net Income VS EBIT VS OCF VS FCFFLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

The Return On Assets of FLD (-3.58%) is worse than 81.43% of its industry peers.
FLD has a worse Return On Equity (-4.35%) than 77.22% of its industry peers.
Industry RankSector Rank
ROA -3.58%
ROE -4.35%
ROIC N/A
ROA(3y)-0.15%
ROA(5y)N/A
ROE(3y)-0.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FLD Yearly ROA, ROE, ROICFLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FLD Yearly Profit, Operating, Gross MarginsFLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for FLD has been reduced compared to 1 year ago.
The debt/assets ratio for FLD is higher compared to a year ago.
FLD Yearly Shares OutstandingFLD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
FLD Yearly Total Debt VS Total AssetsFLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 11.29 indicates that FLD is not in any danger for bankruptcy at the moment.
FLD has a Altman-Z score of 11.29. This is amongst the best in the industry. FLD outperforms 94.09% of its industry peers.
FLD has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.15, FLD is in the better half of the industry, outperforming 78.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 11.29
ROIC/WACCN/A
WACCN/A
FLD Yearly LT Debt VS Equity VS FCFFLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.10 indicates that FLD may have some problems paying its short term obligations.
FLD has a worse Current ratio (0.10) than 92.83% of its industry peers.
A Quick Ratio of 0.10 indicates that FLD may have some problems paying its short term obligations.
The Quick ratio of FLD (0.10) is worse than 92.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
FLD Yearly Current Assets VS Current LiabilitesFLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

FLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -4187.09%.
EPS 1Y (TTM)-4187.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3829.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-931.85%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FLD Yearly Revenue VS EstimatesFLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 10M 20M 30M 40M
FLD Yearly EPS VS EstimatesFLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FLD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FLD Price Earnings VS Forward Price EarningsFLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLD Per share dataFLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FOLD HOLDINGS INC

NASDAQ:FLD (8/8/2025, 8:00:00 PM)

After market: 4.15 +0.14 (+3.49%)

4.01

-0.01 (-0.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners14.19%
Inst Owner ChangeN/A
Ins Owners27.42%
Ins Owner Change16.94%
Market Cap186.18M
Analysts80
Price Target8.67 (116.21%)
Short Float %2.55%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)21.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-41.67%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-11.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.34
P/tB 4.34
EV/EBITDA N/A
EPS(TTM)-1.99
EYN/A
EPS(NY)-1.29
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.92
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.58%
ROE -4.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.15%
ROA(5y)N/A
ROE(3y)-0.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 11.29
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4187.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3829.65%
EPS Next Y-931.85%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.44%
OCF growth 3YN/A
OCF growth 5YN/A